Ironwood pharmaceuticals inc.官网
WebIRONWOOD PHARMACEUTICALS INC has an Investment Rating of HOLD; a target price of $11.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a … WebApr 10, 2024 · See how Ironwood Pharmaceuticals compares to its main competitors: Hoffmann-LA Roche Inc has the most employees (101,200). Employees at AstraZeneca earn more than most of the competitors, with an average yearly salary of $112,988.
Ironwood pharmaceuticals inc.官网
Did you know?
WebAbout us. At Ironwood Pharmaceuticals, we are committed to advancing the treatment of GI diseases and redefining the standard of care for GI patients. As a pioneer and champion … WebApr 13, 2024 · Ironwood Pharmaceuticals. Inc. (US) Edusa Pharmaceuticals (US) Tioga Pharmaceuticals. Inc. (US) Pharmos Corporation (US) Salix Pharmaceuticals. Inc. (US) Abbott Laboratories (US) Lexicon Pharmaceuticals (US) Dalian Xindie Chitin Co. Ltd. (China) Sucampo Pharmaceuticals. Inc. (US) 产品种类细分： 类型 1. 类型 2. 类型 3. 下游应用 ...
WebApr 11, 2024 · finance.yahoo.com - February 10 at 10:29 AM. Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call. finance.yahoo.com - February 2 at 6:17 PM. Ironwood Pharmaceuticals (NASDAQ:IRWD) shareholders are up 3.7% this past week, but still in the red over the last five years.
WebConnect Pharmaceuticals Llc is located at 621 E State St, EAGLE 83616, United States. You can call them via phone number 2082442091. Directionus.com. Connect Pharmaceuticals … WebJul 22, 2024 · BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its second quarter 2024 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, August 5, 2024. Individuals interested in participating in the call should dial (833) 350-1432 (U.S. and Canada) or (647) 689-6932 …
WebApr 10, 2024 · Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation under the LINZESS …
WebIronwood Pharmaceuticals, Inc is a publicly traded pharmaceutical company. It was originally called Microbia, Inc. Microbia was founded by postdocs from the lab of Gerald … fits with blue jeansWebApr 12, 2024 · Ironwood Pharmaceuticals, Inc. has a 1 year low of $9.73 and a 1 year high of $12.66. The company has a market cap of $1.66 billion, a price-to-earnings ratio of 11.10 and a beta of 0.95. can i download instagram app on xboxWebIronwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI … Mr. Emany has served as our chief financial officer since December 2024. Prior to … The Boston Globe named Ironwood Pharmaceuticals a Top Place to Work for … Our in-market product, LINZESS® (linaclotide), discovered in-house, is the … Ironwood Pharmaceuticals wants to make our careers website accessible to all … In November 2024 into a collaboration and license option agreement with COUR … Ironwood Pharmaceuticals. 100 Summer Street Suite 2300 Boston MA 02110. … At Ironwood, how we do things is as important as what we do. Ironwood … By providing your email address below, you are providing consent to Ironwood … One in five Americans suffer from GI diseases, resulting in millions of hospital … can i download itunes books to my kindleWebDec 16, 2024 · IRONWOOD PHARMACEUTICALS, INC. : News, information and stories for IRONWOOD PHARMACEUTICALS, INC. Nasdaq: IRWD Nasdaq can i download iobit surfing protectionWebApr 1, 2024 · Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI-focused healthcare company, today announced that it has completed the tax-free spin-off of its sol fits with crocsWebOct 23, 2012 · Tuesday, 23 October 2012. AstraZeneca and Ironwood Pharmaceuticals, Inc. announced today an agreement to co-develop and co-commercialise Ironwood’s linaclotide in China. Linaclotide is the first and only guanylate cyclase-C (GC-C) agonist approved by the US Food and Drug Administration, in August, for irritable bowel syndrome with ... fitsw loginWeb1 day ago · Ironwood Pharmaceuticals Reports Second Quarter 2024 Results; Maintains Full Year Guidance Due to Continued Strength of LINZESS® Prescription Demand. BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today reported its second quarter 2024 results and recent business performance. fits with black jeans